LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

AJANTPHARM

NSEBSE
Ajanta Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE031B01049· Scrip: 532331
ENहिन्दीગુજરાતીमराठी
3,097.90
200.30 (+6.91%)
6/5/2026, 3:28:22 pm
NSE
3,097.90
200.30
+6.91%
BSE
3,093.25
192.35
+0.00%
2,3762,5662,7562,9453,13504-3006-2608-2210-2112-1802-1704-2404-30
245 trading days · 1Y period
TODAY
Open2,958.10
High3,115.00
Low2,924.90
Prev Close2,897.60
Volume7.54L
Value₹230.0Cr
L: 2,924.90H: 3,115.00
52 WEEK
Low2,329.90
High3,228.00
86% of 52W range
Info
Face Value₹2
Listed2000-05-29
ISININE031B01049
SeriesA
BSE Scrip532331

Key Metrics

1D
+0.72%
1W
+1.57%
1M
-1.35%
3M
+5.23%
6M
+15.83%
Valuation
Mkt Cap₹38225 Cr
Growth (QoQ)
Revenue-3.41%
PAT+7.58%
EPS+7.70%
Profitability
Dividend
Yield0.99%
Growth+0.00%
TTM Revenue
₹4464 Cr
TTM EBITDA
₹1324 Cr
TTM PAT
₹888 Cr
TTM EPS
₹70.74
Rev/Share
₹357.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr297 Cr593 Cr890 Cr1187 Cr22-1223-0323-0923-1224-0324-0624-0924-1210.59.515.516.716.118.817.318.6
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-311146 Cr869 Cr343 Cr307 Cr233 Cr18.60
2024-09-301187 Cr916 Cr325 Cr290 Cr216 Cr17.27
2024-06-301077 Cr795 Cr343 Cr311 Cr236 Cr18.77
2024-03-311054 Cr812 Cr312 Cr278 Cr203 Cr16.10
2023-12-311105 Cr828 Cr325 Cr291 Cr210 Cr16.68
2023-09-301028 Cr774 Cr310 Cr276 Cr195 Cr15.51
2023-03-31882 Cr767 Cr185 Cr152 Cr122 Cr9.54
2022-12-31972 Cr838 Cr202 Cr168 Cr135 Cr10.50

Shareholding Pattern

CURRENT2026-03-31
66.3%PROMOTER
Promoter66.3%
FII8.3%
DII18.4%
Public33.8%
Govt0.0%
PROMOTER HOLDING TREND
66.3%24-0666.3%24-0966.3%24-1266.3%25-0366.3%25-0966.3%25-1266.3%26-03

Corporate Actions

Ex-DateTypePurpose
2025-11-10DividendInterim Dividend - Rs 28 Per Share
2024-11-06DividendInterim Dividend - Rs 28 Per Share
2024-05-30OtherBuy Back
2024-02-08DividendInterim Dividend - Rs 26 Per Share
2023-08-04DividendInterim Dividend - Rs 10 Per Share/Special Dividend - Rs 15 Per Share
2023-03-24OtherBuy Back
2022-11-11DividendInterim Dividend - Rs 7 Per Share
2022-06-22BonusBonus- 1:2
2022-01-13BuybackBuyback
2021-11-09Dividend Interim Dividend - Rs 9.50 Per Share
2020-11-12Buyback Buyback
2020-11-12Dividend Interim Dividend - Rs 9.50 Per Share
2020-07-21Other Annual General Meeting
2019-11-15Dividend Interim Dividend - Rs 13 Per Share
2019-07-09Other Annual General Meeting
2019-02-11Other Buy Back
2018-11-09Dividend Interim Dividend - Rs 9 Per Sh
2018-06-26Other Annual General Meeting
2017-06-23Other Annual General Meeting
2017-03-23Dividend Interim Dividend Rs 7/- Per Share (Purpose Revised)

Earnings Transcripts

Ajanta Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor ...
10 Nov 2022NSE1K chars
Read →
Vide our letter dated 27th October 2022, we had intimated about the Earnings Conference Call schedul...
28 Oct 2022NSE3K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor ...
3 Aug 2022NSE43K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ...
14 May 2022NSE1K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ...
31 Jan 2022NSE1K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Schedule of meet of Earnings Conference Call
27 Jan 2022NSE2K chars
Read →
Ajanta Pharma Limited has informed the Exchange about Link of Recording of Earnings call
29 Oct 2021NSE1K chars
Read →
Ajanta Pharma Limited has informed the Exchange about revised Schedule meet of Earnings Conference C...
26 Oct 2021NSE3K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
31 Jul 2019NSE8K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
30 Apr 2019NSE13K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation
30 Jan 2019NSE11K chars
Read →
Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation for Q3 2018
25 Jan 2018NSE
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-302,790.002,843.802,790.002,822.7059,221
2026-04-292,774.002,820.002,760.002,804.2045,523
2026-04-282,822.002,825.002,740.802,756.0045,413
2026-04-272,765.202,828.002,754.202,807.2063,772
2026-04-242,801.802,818.002,755.002,765.3047,736
2026-04-232,770.002,826.902,760.002,780.8050,252
2026-04-222,781.502,815.402,749.302,779.2051,141
2026-04-212,784.002,816.002,776.002,791.201.39L
2026-04-202,790.202,816.002,768.502,781.3071,748
2026-04-172,829.802,865.902,782.602,790.201.15L
2026-04-162,928.702,928.702,811.002,827.6088,098
2026-04-152,925.002,934.002,880.002,883.2081,682
2026-04-132,797.002,930.302,758.802,897.301.58L
2026-04-102,770.002,835.002,750.002,806.0055,685
2026-04-092,710.402,764.602,699.002,751.0076,542
2026-04-082,766.002,783.602,696.602,709.001.15L
2026-04-072,729.102,766.502,700.002,711.6051,516
2026-04-022,816.002,816.802,722.802,791.2052,986
2026-04-012,849.902,880.002,790.602,816.8064,876
2026-03-272,879.902,919.902,780.302,807.9090,248
2026-03-252,910.002,957.802,864.602,879.9088,697
2026-03-242,821.102,881.602,778.902,863.2072,167
2026-03-202,973.203,020.002,872.502,904.701.11L
2026-03-193,009.003,071.602,931.002,943.9097,655
2026-03-183,049.903,114.103,029.303,056.601.27L
2026-03-172,980.703,071.602,959.003,020.602.30L
2026-03-163,020.003,061.202,930.002,954.101.86L
2026-03-133,136.803,228.003,006.503,030.601.55L
2026-03-123,040.003,150.003,020.003,119.502.98L
2026-03-113,022.003,081.603,010.403,048.201.07L

Frequently Asked Questions

About

Ajanta Pharma Limited, listed on the National Stock Exchange of India (NSE) under the symbol AJANTPHARM, is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and marketing of generic and specialty medicines. Key products include drugs for cardiovascular health, respiratory conditions, and central nervous system disorders, with a strong focus on anti-histamines and anti-depressants. Notably, the company has a long-standing presence in the Indian pharmaceutical sector, contributing significantly to affordable healthcare solutions.

Advertisement
BOARD OF DIRECTORS
Andheri
Executive Director
Anjana Grewal
Independent Director
DEPARTED

Mutual Fund Holdings

9 funds · bar length = % to NAVBrowse all funds →
hdfc2 schemes
HDFC Large and Mid Cap Fund
0.99%
₹2.5K Cr
HDFC NIFTY MIDCAP 150 INDEX FUND
0.34%
₹2 Cr
baroda7 schemes
Baroda BNP Paribas Health and Wellness Fund
0.02%
₹10 Cr
Baroda BNP Paribas Flexi Cap Fund
0.01%
₹15 Cr
Baroda BNP Paribas Large & Mid Cap Fund
0.01%
₹20 Cr